Vaginal agenesis is a condition in which the vagina fails to develop fully or at all before birth, affecting roughly 1 in 4,000 to 1 in 10,000 females. The most common cause is Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome, in which the uterus and upper vagina are absent while external genitalia, chromosomes, and hormone levels remain typical. Most people learn they have it in their teens, when menstruation never arrives, and the news can feel overwhelming. But both non-surgical and surgical treatments produce strong functional results, and reproductive paths that once seemed closed are increasingly accessible.
Why the Vagina Does Not Form
During early fetal development, a pair of structures called the Müllerian ducts normally fuse and extend downward to form the uterus, cervix, and upper portion of the vagina. Cells from the urogenital sinus then migrate upward to line the vaginal canal. When these ducts fail to develop properly, the result can range from a shortened vagina to a complete absence of both the vagina and uterus.1American Journal of Obstetrics and Gynecology. The embryologic development of the human vagina People with MRKH syndrome carry a normal 46,XX chromosome set, have functioning ovaries, and go through typical puberty in every visible way: breast development, pubic hair, growth spurts. Their external genitalia look completely ordinary. The internal structures are what differ.
How It Is Usually Discovered
The classic scenario is a teenager who has gone through all the expected pubertal changes but has not had a first period by age 15 or 16. A visit to a gynecologist typically reveals a shallow vaginal dimple or a short vaginal pouch, and imaging confirms the absence of a uterus. In some cases the condition is found incidentally during imaging for unrelated problems, or because a tampon cannot be inserted. Because the outward signs of puberty appear on schedule, many families and even some clinicians initially assume the delayed period is just a late bloomer situation, which can extend the time to diagnosis.
MRI is the standard imaging tool, but it is not infallible. One study found that MRI had a sensitivity of only about 53% for accurately detecting uterine anomalies when compared against what laparoscopy actually showed.2PubMed. A comparison of MRI and laparoscopy in detecting pelvic structures in cases of vaginal agenesis An earlier analysis put that sensitivity even lower, around 31%, with MRI sometimes missing small rudimentary uterine horns entirely.3Journal of Pediatric and Adolescent Gynecology. MRI Sensitivity in Detecting Uterine Agenesis in Cases of Vaginal Agenesis A large retrospective review of 92 patients used MRI to classify uterine remnant patterns into three groups: complete uterine agenesis, a single rudimentary horn on one side, or bilateral rudimentary horns.4PubMed. Evaluation of Mayer-Rokitansky-Küster-Hauser syndrome with magnetic resonance imaging MRI is still the best non-invasive starting point, but clinicians sometimes need laparoscopy to get the full picture, especially when treatment decisions hinge on exactly what remnants are present.
Types and Associated Anomalies
MRKH syndrome comes in two recognized forms. Type I is isolated, meaning the only issue is the absent vagina and uterus. Type II involves additional birth differences in other organ systems, most commonly the kidneys, the spine, and occasionally the heart.5Radiology Case Reports. Mayer-Rokitansky-Kuster-Hauser syndrome type II with crossed fused renal ectopia In a review of 69 females with vaginal agenesis, kidney abnormalities appeared in about 43%, vertebral differences in 29%, and cardiac anomalies in roughly 15%.6PubMed. Vaginal agenesis, the hymen, and associated anomalies That kidney figure is high enough that anyone diagnosed with vaginal agenesis should have renal imaging as part of their workup, even if they have no urinary symptoms.
Vaginal agenesis also occurs in conditions other than MRKH. Complete androgen insensitivity syndrome (CAIS), for example, produces vaginal and uterine agenesis in individuals with a 46,XY karyotype whose bodies cannot respond to androgens, resulting in a female external appearance.7PubMed. Complete androgen insensitivity syndrome–a review The management and emotional landscape overlap, but the underlying biology is different, which matters for decisions about gonads and hormone therapy.
What Genetics Has and Has Not Explained
Families often ask whether MRKH runs in the family or could recur in a future child. The honest answer is that genetics has made progress but has not identified a single “cause” gene. One study narrowed a field of 72 candidate genes down to 10 that appear more likely to be involved, and identified what may be a combination of two genes working together in at least one patient.8PubMed Central. Genetics of agenesis/hypoplasia of the uterus and vagina: narrowing down the number of candidate genes for Mayer-Rokitansky-Küster-Hauser Syndrome Separate work identified a deletion on chromosome 17 that removes portions of two genes, HNF1B and LHX1, both of which play roles in the development of the reproductive tract.9PubMed Central. Functional genomics analysis identifies loss of HNF1B function as a cause of Mayer-Rokitansky-Küster-Hauser syndrome
The emerging picture is that MRKH is likely a genetically complex condition rather than a simple one-gene disorder. Multiple genes may each contribute a small push, and possibly environmental factors during early pregnancy play a role too. For now, there is no standard genetic test that predicts MRKH, and most cases appear sporadically rather than following a clear inheritance pattern.
Vaginal Dilator Therapy
International guidelines recommend dilator therapy as the first-line approach for creating a functional vagina, ahead of any surgery. The concept is straightforward: a set of smooth, graduated cylinders are pressed against the vaginal dimple for short daily sessions, gradually stretching tissue to form a canal. It requires no anesthesia, no incisions, and no hospital stay.
A large series of 245 consecutive patients managed by a multidisciplinary team reported that among those who completed the program, about 95% achieved a vaginal length greater than 6 centimeters and satisfactory sexual function. Among those who stayed with it through the full course, every single patient was successful.10Fertility and Sterility. Mayer-Rokitansky-Küster-Hauser syndrome: a review of 245 consecutive cases managed by a multidisciplinary approach with vaginal dilators The authors concluded that surgery is rarely, if ever, required when dilator therapy is properly supported.
That “properly supported” qualifier is important. Dilator therapy demands motivation, privacy, consistent effort over weeks to months, and ideally access to a knowledgeable physiotherapist or nurse specialist. For teenagers, it can feel awkward or emotionally difficult. Some patients find it easier to start dilators after they are already in a relationship, while others prefer to complete the process before dating. There is no single right timeline, and clinicians increasingly let the patient drive the pace.
Surgical Options When Dilators Are Not Enough
When dilator therapy is not feasible or does not produce adequate results, several surgical techniques can create a neovagina. Each has trade-offs in complexity, recovery time, and long-term maintenance.
- Vecchietti procedure: A device applies traction from inside the abdomen to pull the vaginal dimple inward, creating a canal over several days. A modified laparoscopic version achieved a mean neovaginal length of about 8 centimeters at the first follow-up and sexual function scores comparable to controls.11PubMed Central. Creation of a Neovagina by Laparoscopic Modified Vecchietti Technique: Anatomic and Functional Results An optimized version with redesigned instruments cut operative time in half and achieved even longer neovaginal length, around 10.6 centimeters at six months, with no patients needing lubricants or reporting sustained pain during intercourse.12PubMed. Neovagina creation in vaginal agenesis: development of a new laparoscopic Vecchietti-based procedure and optimized instruments
- Peritoneal vaginoplasty: The surgeon lines the newly created vaginal space with a flap of peritoneum, the thin membrane that lines the abdomen. In one series using a laparoscopic approach, the mean neovaginal length was about 8.3 centimeters at nearly 19 months’ follow-up with no shrinkage, and sexual function scores were statistically indistinguishable from a comparison group.13Journal of Minimally Invasive Gynecology. Laparoscopic Peritoneal Vaginoplasty (Modified Admyan’s Technique) for Vaginal Agenesis in Mayer-Rokitansky-Küster-Hauser Syndrome A related technique, the Davydov-Moore procedure, reported vaginal length after surgery roughly eight times longer than the starting dimple, with comfort scores improving dramatically and no vaginal stenosis during follow-up.14PubMed Central. Davydov-Moore vaginoplasty in Mayer-Rokitansky-Küster-Hauser syndrome: sexual and surgical outcomes
- Graft-based techniques: Skin grafts, intestinal tissue, or bioengineered scaffolds can be used to line the neovaginal space. A ten-year study comparing a porcine intestinal scaffold against homologous skin grafts found similar vaginal dimensions at six months, but the scaffold group had shorter surgery, less bleeding, and higher sexual function scores.15PubMed Central. Comparing Anatomical and Functional Outcomes of Two Neovaginoplasty Techniques for Mayer-Rokitansky-Küster-Hauser Syndrome
- Sigmoid vaginoplasty: A segment of the sigmoid colon is used to form the vaginal canal. This approach offers natural lubrication because the intestinal lining produces mucus. Long-term follow-up over a mean of seven and a half years found satisfactory cosmetic and functional results, with mild early complications like excess mucus and transient discomfort that resolved.16PubMed Central. Long-term outcomes of sigmoid vaginoplasty in patients with disorder of sexual development However, intestinal vaginoplasty carries a meaningful complication profile. A systematic review of over 650 intestinal vaginoplasties found an overall complication rate of about 33%, with stenosis, excess mucus, vaginal prolapse, and odor being the most common issues, and roughly 18% of patients needing a return trip to the operating room.17PubMed. Operative Management of Complications Following Intestinal Vaginoplasty: A Case Series and Systematic Review
No single surgical technique has emerged as definitively superior. The choice depends on the surgeon’s expertise, the patient’s anatomy, and personal preferences around recovery time, maintenance requirements, and lubrication needs. All approaches require some period of post-surgical dilation to prevent the neovagina from narrowing.
Sexual Function After Treatment
One of the first questions patients and their families have is whether a satisfying sex life is realistic. Across multiple surgical techniques and dilator therapy, the answer is consistently yes. Studies using standardized sexual function questionnaires show that treated patients routinely reach scores in the same range as women without vaginal agenesis. After vaginoplasty with an acellular dermal matrix, for instance, function scores were essentially identical to a control group.18PubMed. Long-term Results of Sexual Function and Body Image After Vaginoplasty With Acellular Dermal Matrix in Women With Mayer-Rokitansky-Küster-Hauser Syndrome A different graft-based series reported that about 42% of patients had sexual function restored, with a somewhat lower average score, suggesting outcomes can vary depending on technique, follow-up duration, and individual factors.19PubMed. The long-term outcomes of vaginoplasty using acellular porcine small intestinal submucosa grafts in patients with Mayer-Rokitansky-Küster-Hauser syndrome
It is worth emphasizing that the clitoris, labia, and all external erogenous tissue develop normally in MRKH. Orgasm is entirely possible regardless of whether a neovagina has been created, because the nerve pathways involved are intact. Treatment is about enabling penetrative intercourse and, for many patients, the psychological relief of feeling “complete,” not about the capacity for pleasure itself.
Uterine Remnants and Pelvic Pain
Many people assume that if the uterus did not form, there is nothing left to cause trouble. That is often wrong. In one study, about half of females with MRKH had identifiable uterine remnants, and a similar proportion reported pelvic pain. When those remnants contained functional endometrial tissue, the risk of pelvic pain more than doubled. Endometriosis was found in over half of the patients with pain who underwent laparoscopy, and at stages more advanced than typically seen in teenagers. Laparoscopic removal of the remnants resolved the pain.20PubMed. Uterine remnants and pelvic pain in females with Mayer-Rokitansky-Küster-Hauser syndrome A larger 10-year review from a specialist center found remnants in over 90% of women imaged, and confirmed that those with functional remnants were significantly more likely to experience pain.21PubMed Central. Magnetic resonance imaging and clinical features of Mayer-Rokitansky-Küster-Hauser syndrome: A 10-year review from a dedicated specialist centre The takeaway for patients: if you have been diagnosed with MRKH and develop cyclical or chronic pelvic pain, it is not “all in your head.” Functional remnant tissue can behave like a miniature uterus, building up and causing real pain that deserves evaluation.
Paths to Parenthood
Because the ovaries function normally, people with MRKH produce their own eggs. The absence of a uterus means they cannot carry a pregnancy themselves, but their eggs can be fertilized through IVF and transferred to a gestational surrogate. A systematic review of this approach found a live birth rate of about 18% per IVF cycle and about 54% per patient across multiple cycles.22Reproductive BioMedicine Online. The reproductive potential of patients with Mayer–Rokitansky–Küster–Hauser syndrome using gestational surrogacy: a systematic review A separate analysis comparing patients with typical and atypical MRKH forms found that pregnancy rates per cycle were similar between the two groups, although ovarian stimulation was somewhat more demanding in the atypical form.23Human Reproduction. Surrogate in vitro fertilization outcome in typical and atypical forms of Mayer–Rokitansky–Küster–Hauser syndrome
Uterine transplantation is a newer and more dramatic option. By 2017, 42 women worldwide had received transplanted uteruses and 11 babies had been born as a result.24PubMed Central. Uterus Transplantation as a Therapy Method in Mayer-Rokitansky-Küster-Hauser Syndrome A landmark case in Brazil later demonstrated the first live birth from a uterus transplanted from a deceased donor, removing the need for a living donor to undergo major surgery.25The Lancet. Livebirth after uterus transplantation from a deceased donor in a patient with Mayer-Rokitansky-Küster-Hauser syndrome Uterine transplant remains experimental and available at only a handful of centers worldwide, but numbers have grown since those early reports. The transplanted uterus is removed after the patient has completed childbearing, so it is a temporary graft rather than a permanent implant. Adoption remains another well-established route, of course, and many patients ultimately choose it.
The Emotional Weight of the Diagnosis
Receiving a diagnosis of vaginal agenesis during adolescence can be psychologically shattering. You are told, typically at an age when your identity is still forming, that a part of your body most people take for granted simply is not there. Research confirms that the emotional burden is real: women with MRKH show higher rates of phobic anxiety, feelings of interpersonal alienation, and trends toward depression and anxiety compared to peers.26PubMed. Psychological distress in women with uterovaginal agenesis (Mayer-Rokitansky-Kuster-Hauser Syndrome, MRKH)
How the diagnosis is communicated matters. A qualitative study of women in Denmark found that younger patients needed more time to build trust with their healthcare provider, and that forcing a genital examination at the first appointment could be counterproductive. Allowing the young woman to decide when she is ready for a physical exam led to a better experience.27Journal of Pediatric and Adolescent Gynecology. Understanding the Diagnostic Odyssey of Women with Mayer-Rokitansky-Küster-Hauser (MRKH) Syndrome in Denmark Research on adolescent sexuality in MRKH echoes this, recommending gradual disclosure of information and flexible timing for starting dilator therapy, rather than pressing for immediate treatment.28PubMed. The Sexuality of Adolescents and Young Women With MRKH Syndrome: A Qualitative Study A systematic review of adolescent management identified diagnosis disclosure, coping with infertility, threats to self-image, and navigating relationships as the key areas where patients need support.29PubMed Central. Treatment management during the adolescent transition period of girls and young women with Mayer-Rokitansky-Küster-Hauser syndrome (MRKHS) Peer support groups, in person or online, are often described by patients as one of the most helpful resources, sometimes even more so than professional counseling, simply because speaking with someone who has lived through the same experience removes the isolation.
What Happens Inside a Neovagina Over Time
Whether created by dilators or surgery, a neovagina is not identical to a vagina that developed in the womb. One of the more fascinating questions researchers have explored is what kind of microbial community takes hold. In a longitudinal study of patients who had peritoneal vaginoplasty, the early microbial picture was chaotic, with a bloom of gut-associated bacteria. By six to twelve months, the community began to resemble a typical vagina, though with a profile more consistent with bacterial vaginosis. By two to four years after surgery, the microbiome had settled into a structure resembling the patient’s original vaginal-dimple skin.30Nature Communications. Insights into the assembly of the neovaginal microbiota in Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome patients
A systematic review across different surgical techniques found that the neovaginal microbiome tends to reflect the tissue it was built from: intestinal grafts harbored gut-like bacteria, while skin-based constructions were more polymicrobial but shared some features with typical vaginal flora. Lactobacillus, the bacterium that dominates healthy vaginal environments, was identified in several neovaginal types, possibly arriving via migration from the rectum or through probiotic use.31PubMed. Systematic Review: The Neovaginal Microbiome This research is still in early stages, but it has practical implications. Patients who develop recurrent infections, unusual discharge, or odor after neovaginoplasty may benefit from microbiome-informed management rather than repeated rounds of standard antibiotics. Clinicians familiar with neovaginal biology are better positioned to distinguish between a normal post-surgical microbial shift and a genuine infection.